Par Drugs And Chemicals Limited

· Unclassified

Annual Quarterly₹ CrorePeersBALAXI CROWN STEELCITY HINDCON LATTEYS HECPROJECT AIROLAM GROBTEA

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	95.6	101.0	103.7	108.9
Other Income	0.2	2.2	4.0	3.1
Total Income	95.9	103.1	107.7	112.0
Expenses
+ Cost of Materials Consumed	33.3	39.4	42.7	44.3
+ Changes in Inventories	0.5	-1.3	0.7	1.4
+ Employee Benefit Expense	5.5	5.9	6.1	6.4
+ Finance Costs	0.1	0.1	0.1	0.1
+ Depreciation & Amortisation	3.4	3.6	3.7	3.8
+ Other Expenses	33.5	37.5	37.0	36.8
Total Expenses	76.4	85.2	90.4	92.8
EBITDA	22.8	19.5	17.1	20.0
EBIT	19.4	15.9	13.4	16.2
Profit
PBT before Exceptional Items	19.5	17.9	17.3	19.2
Pretax Income	19.5	17.9	17.3	19.2
+ Current Tax	5.0	4.5	4.5	5.0
+ Deferred Tax	0.0	0.0	-0.3	-0.3
Tax Expense	5.0	4.6	4.2	4.7
Net Income	14.5	13.4	13.1	14.5
+ Net Income — Continuing Ops	14.5	13.4	13.1	14.5
Total Comprehensive Income	14.5	13.4	13.1	14.5
Per Share
Basic EPS	11.78	10.86	10.65	11.78
Diluted EPS	11.78	10.86	10.65	11.78
Per Share — as-filed variants
Basic EPS — Continuing Operations	11.78	10.86	10.65	11.78
Diluted EPS — Continuing Operations	11.78	10.86	10.65	11.78
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	61.8	62.8	60.3	63.1
Gross Margin %	64.67	62.24	58.17	57.97
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	19.5	17.9	17.3	19.2
Net Income Adj (tax-effected)	14.5	13.4	13.1	14.5
EPS Adj	11.78	10.86	10.65	11.78
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00
Paid Up Equity Capital	12.3	12.3	12.3	12.3

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.